PYRIDINONE AND PYRIMIDINONE COMPOUNDS

Details for Australian Patent Application No. 2002351920 (hide)

Owner SMITHKLINE BEECHAM P.L.C.

Inventors LEACH, Colin, Andrew; SMITH, Stephen, Allan

Pub. Number AU-A-2002351920

PCT Number PCT/EP02/12504

PCT Pub. Number WO2003/042206

Priority 0127139.4 10.11.01 GB

Filing date 8 November 2002

Wipo publication date 26 May 2003

International Classifications

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 009/10 Drugs for disorders of the cardiovascular system

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/36 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 239/95 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/56 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 0127139.4 10.11.01 GB

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002351920

29 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351921-Heterocyclic derivatives of glycinamide and their medical use

2002351919-ANTISENSE OLIGONUCLEOTIDES MODULATING BCL-2 EXPRESSION